PD 1 checkpoint inhibition in solid organ transplants: 2 sides of a coin – case report
Abstract Background The management of malignancy post kidney transplantation includes reduction in immunosuppression and referral to an oncologist management of their malignancy. Recent advances in oncology have resulted in the approval of several classes of drugs with immune-modulatory activity. Ho...
Main Authors: | Jonathan W. Goldman, Basmah Abdalla, Melody A. Mendenhall, Anthony Sisk, Jaime Hunt, Gabriel M. Danovitch, Erik L. Lum |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-08-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12882-018-1003-5 |
Similar Items
-
Suppression of Inflammation-Associated Kidney Damage Post-Transplant Using the New PrC-210 Free Radical Scavenger in Rats
by: Torsten R. Goesch, et al.
Published: (2021-07-01) -
The causes and frequency of kidney allograft failure in a low-resource setting: observational data from Iraqi Kurdistan
by: Alaa Abbas Ali, et al.
Published: (2021-08-01) -
Diagnostic possibilities of using micro-RNA for kidney transplantation
by: I. A. Pirozhkov, et al.
Published: (2018-09-01) -
Tackling Chronic Kidney Transplant Rejection: Challenges and Promises
by: Xingqiang Lai, et al.
Published: (2021-05-01) -
Rationale and design of the RIACT–study: a multi-center placebo controlled double blind study to test the efficacy of RItuximab in Acute Cellular tubulointerstitial rejection with B-cell infiltrates in renal Transplant patients: study protocol for a randomized controlled trial
by: Schiffer Lena, et al.
Published: (2012-10-01)